YU28203A - Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence - Google Patents

Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence

Info

Publication number
YU28203A
YU28203A YU28203A YUP28203A YU28203A YU 28203 A YU28203 A YU 28203A YU 28203 A YU28203 A YU 28203A YU P28203 A YUP28203 A YU P28203A YU 28203 A YU28203 A YU 28203A
Authority
YU
Yugoslavia
Prior art keywords
phenylimino
amino
urinary incontinence
novel
treating urinary
Prior art date
Application number
YU28203A
Other languages
Serbo-Croatian (sh)
Inventor
Pascale Pouzet
Franz Esser
Hisato Kitagawa
Kenji Sakai
Ikunobu Muramatsu
Original Assignee
Boehringer Ingelheim Pharma Gmbh. & Co.Kg.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh. & Co.Kg. filed Critical Boehringer Ingelheim Pharma Gmbh. & Co.Kg.
Publication of YU28203A publication Critical patent/YU28203A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention relates to m-amino-phenylimino-imidazolidine derivatives with a novel substituent pattern on the phenyl ring, of general formula (I) or of general formula (II), wherein R1 is F, Cl, Br, CH2F, CF2H or CF3, R2 is NR6R7, R6 being Me, Et, Pr or iPr and R7 being Me, Et or Pr; and R3, R4 and R5 are each, independently of each other, H, Me, F, Cl, Br, CH2F, CF2H and/or CF3 and if R4 is Me, F, Cl, Br, CH2F, CF2H or CF3, then R1 is additionally also H or Me; and or their pharmacologically compatible salts, to the use thereof for producing medicaments, especially for treating urinary incontinence, and to a method for producing the same.
YU28203A 2000-10-14 2001-10-11 Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence YU28203A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10051005 2000-10-14

Publications (1)

Publication Number Publication Date
YU28203A true YU28203A (en) 2006-05-25

Family

ID=7659815

Family Applications (1)

Application Number Title Priority Date Filing Date
YU28203A YU28203A (en) 2000-10-14 2001-10-11 Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence

Country Status (23)

Country Link
EP (1) EP1328517A2 (en)
JP (1) JP2004511547A (en)
KR (1) KR20030046503A (en)
CN (1) CN1471514A (en)
AR (1) AR035923A1 (en)
AU (1) AU2002215943A1 (en)
BG (1) BG107711A (en)
BR (1) BR0114603A (en)
CA (1) CA2425563A1 (en)
CZ (1) CZ20031333A3 (en)
DE (1) DE10150312A1 (en)
EA (1) EA200300460A1 (en)
EC (1) ECSP034517A (en)
EE (1) EE200300177A (en)
HU (1) HUP0302245A3 (en)
IL (1) IL155338A0 (en)
MX (1) MXPA03003162A (en)
NO (1) NO20031697L (en)
PL (1) PL361359A1 (en)
SK (1) SK4342003A3 (en)
WO (1) WO2002032876A2 (en)
YU (1) YU28203A (en)
ZA (1) ZA200302345B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4168086B1 (en) * 2008-04-16 2008-10-22 国立大学法人福井大学 Imidazoline derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2806811A1 (en) * 1978-02-17 1979-08-23 Boehringer Sohn Ingelheim NEW SUBSTITUTED 2-PHENYLIMINO-IMIDAZOLIDINE, THEIR ACID-ADDITIONAL SALTS, THESE MEDICINAL PRODUCTS AND METHOD FOR MANUFACTURING THE SAME
CA1201066A (en) * 1981-11-20 1986-02-25 Alcon Laboratories, Inc. N-¬3,5-dichloro-4-(2-imidazolidinylideneamino)- phenyl|-acetamide solutions for lowering intraocular pressure
DE19514579A1 (en) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Use of alpha-1-olone agonists for the treatment of urinary incontinence

Also Published As

Publication number Publication date
AU2002215943A1 (en) 2002-04-29
PL361359A1 (en) 2004-10-04
EP1328517A2 (en) 2003-07-23
EA200300460A1 (en) 2004-02-26
WO2002032876A2 (en) 2002-04-25
HUP0302245A2 (en) 2003-10-28
NO20031697L (en) 2003-05-26
NO20031697D0 (en) 2003-04-11
BG107711A (en) 2004-02-27
CN1471514A (en) 2004-01-28
HUP0302245A3 (en) 2004-01-28
MXPA03003162A (en) 2004-12-06
IL155338A0 (en) 2003-11-23
DE10150312A1 (en) 2002-07-04
CZ20031333A3 (en) 2003-08-13
JP2004511547A (en) 2004-04-15
SK4342003A3 (en) 2003-10-07
WO2002032876A3 (en) 2002-07-18
ECSP034517A (en) 2003-04-25
BR0114603A (en) 2003-10-14
AR035923A1 (en) 2004-07-28
CA2425563A1 (en) 2002-04-25
EE200300177A (en) 2003-08-15
KR20030046503A (en) 2003-06-12
ZA200302345B (en) 2004-04-23

Similar Documents

Publication Publication Date Title
EP1527049B8 (en) Fused heterocyclic compounds as peptidase inhibitors
SG128491A1 (en) Heterocyclic sulfonamide inhibitors of beta amyloid production
ATE326454T1 (en) NEW Succinic ACID DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS
YU69902A (en) New piperazine derivatives
WO2001019798A3 (en) Inhibitors of factor xa
PL371046A1 (en) Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
WO2000071510A3 (en) INHIBITORS OF FACTOR Xa
CA2286723A1 (en) Tricyclic compounds
TW200503712A (en) (2-carboxamido)(3-amino)thiophene compounds
YU94103A (en) Novel sulfonic acid derivatives
YU30603A (en) Bridged piperazine derivatives
WO2003004497A1 (en) Novel heterocyclic compound
TR200302288T2 (en) New compounds and methods for therapy.
TR199900096T2 (en) N-benzenesulfonyl-L-proline derivatives suitable as bradykinin B2 antagonists.
YU28203A (en) Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence
ATE246177T1 (en) KATECHOLHYDRAZONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
MXPA02001406A (en) Substituted heterocyclyl-2h-chromenes.
MXPA04003086A (en) A process for the stereoselective synthesis of 2-hydroxymethyl-chromans.
GB9812211D0 (en) Cinnamoyl distamycin analogous derivatives,process for their preparation,and their use as antitumor agents
NO20031046D0 (en) Process for the preparation of a substituted imidazopyridine compound
RS50449B (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
SE0000382D0 (en) New process
AP2001002195A0 (en) Novel process for the preparation of pyrazolopyrimidinones.
HUP0303004A2 (en) Novel alkyl phenylimino-imidazolidine derivatives, pharmaceutical compositions containing them and their use for preparation of for treating urinary incontinence
PT1140919E (en) NEW 1,4-DISSUBSTITUTED CYCLOHEXAN DERIVATIVES FOR THE TREATMENT OF DEPRESSION